7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
                       
      cash flows from operating activities
                       
      net income
    -80,293,000 -76,531,000 -51,694,000 -43,425,000 -46,632,000 -33,708,000 -28,383,000 -25,655,000 -20,104,000 -20,162,000 -30,069,000 -32,439,000 -24,679,000 -14,853,000 -17,085,000 -16,847,000 -7,611,000 -3,437,000 -4,714,000 
      adjustments to reconcile net income to net cash from operating activities:
                       
      depreciation and amortization
    129,000 119,000 85,000 55,000 24,000               
      accretion of discount and amortization of premium on debt securities
    -1,451,000                   
      accretion of loan exit fee and amortization of loan costs
    843,000 156,000 221,000 217,000 207,000               
      reduction in the carrying amount of operating lease right-of-use assets
    435,000 444,000 457,000 548,000 496,000 503,000 517,000 532,000 549,000 564,000 579,000 595,000 561,000 551,000 564,000     
      stock-based compensation
    9,745,000 9,472,000 7,744,000 6,217,000 5,588,000 4,873,000 4,124,000 3,221,000 2,923,000 2,682,000 2,667,000 2,748,000 2,452,000 2,025,000 1,662,000 962,000 933,000 713,000 404,000 
      payment of vt-109 license fee
    50,000 750,000                 
      changes in operating assets and liabilities:
                       
      prepaid expense and other current assets
    606,000 1,714,000 -5,876,000 496,000 -1,843,000 2,720,000 -392,000 809,000 -2,087,000 -2,298,000 3,749,000 -482,000 -154,000   706,000 632,000 -3,517,000 -127,000 
      other assets
    -108,000 141,000 17,000 9,000 320,000 13,000 9,000 -1,000 -4,000 -299,000 -5,000 -13,000 -66,000 -303,000 271,000     
      accounts payable
    4,793,000 3,895,000 1,597,000 3,063,000 -62,000 -545,000 -5,909,000 -1,182,000 -980,000 7,954,000 -6,665,000 4,979,000 -72,000 -244,000 5,943,000 420,000 -759,000 1,012,000 -198,000 
      accrued and other liabilities
    3,915,000 8,101,000 -4,782,000 -3,767,000                
      operating lease liabilities
    -520,000 -469,000 -394,000 -529,000 -618,000 -623,000 -637,000 -649,000 -651,000 -665,000 -680,000 -693,000 -647,000 -636,000 -626,000     
      net cash from operating activities
    -61,906,000 -54,798,000 -54,406,000 -39,182,000 -36,885,000 -24,782,000 -33,830,000 -25,144,000 -22,973,000 -17,772,000 -26,292,000 -21,162,000 -18,420,000 -19,033,000 -8,981,000 -6,438,000 -5,484,000 -7,665,000 -4,121,000 
      capex
    -133,000 -208,000 -187,000 -645,000 -238,000 -38,000 -6,000 -18,000 
      free cash flows
    -62,039,000 -55,006,000 -54,593,000 -39,827,000 -37,123,000 -24,782,000 -33,830,000 -25,144,000 -22,973,000 -17,772,000 -26,292,000 -21,162,000 -18,458,000 -19,039,000 -8,999,000 -6,438,000 -5,484,000 -7,665,000 -4,121,000 
      cash flows from investing activities
                       
      purchase of property and equipment
    -133,000 -208,000 -187,000 -645,000 -238,000       -38,000 -6,000 -18,000     
      purchase of marketable securities
    -98,696,000 -97,259,000 -89,992,000 -294,015,000 -72,945,000 -81,088,000 -254,967,000 -53,200,000 -28,672,000 -108,849,000 -34,209,000 -10,563,000 -40,403,000 -58,087,000 -39,437,000     
      proceeds from maturities of marketable securities
    168,590,000 126,061,000 106,246,000 73,277,000 111,500,000 58,500,000 31,681,000 71,819,000 44,900,000 22,400,000 36,900,000 24,000,000 38,001,000       
      proceeds from sale of marketable securities
       4,000,000 9,543,000         
      net cash from investing activities
    69,761,000 28,544,000 15,317,000 -221,383,000 38,317,000 -22,677,000 -219,286,000 18,556,000 16,228,000 -86,449,000 12,234,000 13,437,000 -2,440,000 -42,094,000 -39,455,000 -5,000,000   
      cash flows from financing activities
                       
      proceeds from exercise of stock options and employee stock purchase plan
    797,000 464,000 1,533,000 2,311,000 752,000 3,439,000 6,911,000 87,000 297,000 432,000 240,000 827,000 975,000 47,000 234,000     
      proceeds from refinancing under loan and security agreement
                      
      payment of deferred issuance costs related to unfunded loan commitments
                      
      proceeds from short swing settlement
       37,000             
      repurchase of common stock
                      
      proceeds from issuance of common stock in follow-on offering
        287,500,000             
      payment of issuance costs and underwriting fees related to follow-on offering
                       
      net cash from financing activities
    797,000 20,285,000 1,533,000 325,955,000 739,000 3,439,000 276,540,000 24,828,000 297,000 432,000 107,984,000 20,709,000 908,000 48,000 80,268,000 4,921,000 48,989,000 -28,000 
      net decrease in cash and cash equivalents
    8,652,000    2,171,000               
      cash and cash equivalents, beginning of period
    92,646,000                
      cash and cash equivalents, end of period
    8,652,000 -5,969,000 55,090,000  2,171,000               
      supplemental disclosure of cash flow information
                       
      cash paid for interest expense
    1,766,000 1,657,000 1,581,000 1,662,000 1,736,000 1,734,000 1,520,000    3,253,000    104,000     
      addition to right-of-use assets obtained from operating lease liabilities
                       
      accretion of discount and amortization of premium on purchase of debt securities
      -2,531,000 -2,066,000 -2,431,000               
      payment of issuance costs and underwriting fees related to follow-on offerings
                       
      net increase in cash and cash equivalents
      -37,556,000                 
      receivable on exercise of stock options
          13,000             
      proceeds from borrowings, net of costs
                       
      proceeds from issuance of common stock in follow-on offerings
                       
      cash and cash equivalents, beginning of year
                       
      cash and cash equivalents, end of year
                       
      payment of costs and underwriting discounts and commissions related to follow-on offering
        -17,908,000 -7,256,000 67,000        
      cash paid for operating leases
        815,000 764,000 764,000 762,000 746,000 746,000 746,000 743,000 680,000 655,000 656,000     
      accrued and other current liabilities
         4,579,000 -1,690,000 -1,054,000 -1,192,000 -4,606,000 4,637,000 4,745,000 474,000 -2,406,000 4,223,000 3,217,000 1,023,000 84,000 1,069,000 
      depreciation, amortization and accretion
          -1,469,000 -1,167,000 -1,442,000 -971,000 -506,000 -597,000 -152,000 -106,000 9,000 32,000 59,000 50,000 35,000 
      net increase in cash and cash equivalents and restricted cash
          23,424,000    93,926,000 12,984,000 -19,952,000 -61,079,000 31,832,000 -6,517,000 -5,484,000 42,120,000 -4,149,000 
      cash, cash equivalents and restricted cash, beginning of period
          45,681,000  43,752,000  79,967,000  53,997,000 
      cash, cash equivalents and restricted cash, end of period
          69,105,000  -6,448,000 -103,789,000 137,678,000  -19,952,000 -61,079,000 111,799,000  -5,484,000 42,120,000 49,848,000 
      reconciliation of cash and cash equivalents and restricted cash to the balance sheets
                       
      cash and cash equivalents
          69,105,000 18,240,000 -6,448,000 -103,496,000 137,385,000 12,984,000 -19,952,000 -61,079,000 111,506,000 -6,517,000 -5,434,000 42,120,000 49,505,000 
      restricted cash
              293,000 293,000 -50,000 343,000 
      total cash and cash equivalents and restricted cash
          69,105,000 18,240,000 -6,448,000 -103,789,000 137,678,000 12,984,000 -19,952,000 -61,079,000 111,799,000  -5,484,000 42,120,000 49,848,000 
      issuance of class a common stock for licensing payment, net of costs
                       
      change in fair value of non-marketable equity securities
           2,000 15,000 29,000 1,000 64,000 202,000   247,000 364,000   
      proceeds from issuance of class a common stock in follow-on offering
           115,000,000 -1,000        
      cash, cash equivalents and restricted cash, beginning of year
                       
      cash, cash equivalents and restricted cash, end of year
                       
      cash paid for interest
           853,000 863,000   559,000 119,000       
      issuance of class a common stock in payment of licensing fees
                       
      issuance of class a common stock for licensing payment
                       
      net decrease in cash and cash equivalents and restricted cash
            -6,448,000           
      issuance of class a common stock in payment of accrued development milestone
                       
      payment for mau868 asset purchase
                       
      restructuring payments
                   -124,000 -125,000 -160,000 -590,000 
      gain on sale of pnai technology
                     
      proceeds from sale of pnai technology
                     
      proceeds from issuance of class a common stock upon initial public offering, net of underwriting discounts and commissions
                     
      payment of offering costs related to initial public offering
                     
      reclassification of redeemable convertible preferred stock into common stock upon initial public offering
                      
      non-marketable equity securities received as partial proceeds from sale of pnai technology
                      
      lease assignment
                      
      liability assumed in connection with mau868 asset purchase
                       
      payment of costs related to initial public offering
                       
      reclassification of redeemable convertible preferred stock into class a common stock and class b common stock upon initial public offering
                       
      prepaid expenses and other current assets
                  -3,942,000     
      proceeds from issuance of class a common stock offering, net of underwriting discounts and commissions
                  86,130,000     
      payment of costs related to underwritten follow-on offering
                  -6,096,000     
      payment of deferred offering costs
                      -369,000 
      payment on capital lease obligations
                      -1,000 
      deferred offering costs included in accounts payable
                      729,000 
      deferred offering costs included in accrued and other current liabilities
                      195,000 
      impairment loss on property and equipment and intangible asset
                       
      issuance of series c redeemable convertible preferred stock for license
                       
      non-cash interest expense on convertible notes
                       
      issuance costs for convertible notes
                       
      gain on issuance of convertible notes
                       
      change in fair value of convertible notes
                       
      other liabilities
                       
      proceeds from the sale of property and equipment
                       
      proceeds from exercise of stock options
                   208,000 342,000 
      proceeds from issuance of series c redeemable convertible preferred stock
                       
      payment of issuance costs related to issuance of redeemable convertible preferred stock
                       
      proceeds from issuance of convertible notes
                       
      payment of issuance costs related to convertible notes
                       
      payment issuance costs related to convertible promissory notes
                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.